Optimizing PSMA-617-based inhibitors through charged linker modifications: Insights into structure-activity relationships
Theranostics · 2026
DOI: 10.7150/thno.118972 ↗Kurz gefasst
Fachartikel in der Zeitschrift Theranostics, 2026. Verfasst von Nicolas M Geis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106 Freiburg, …. Hauptthemen laut MEDLINE: Heterocyclic Compounds, 1-Ring, Dipeptides, Glutamate Carboxypeptidase II, Prostatic Neoplasms, Castration-Resistant. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nuclear Medicine, University Medical Center Freiburg, Faculty of Medicine, University of Freiburg, Hugstetter Str. 55, 79106 Freiburg, Germany.
- Division of Radiopharmaceutical Development, German Cancer Consortium, Partner Site Freiburg, Hugstetter Str. 55, 79106 Freiburg, Germany, and German Cancer Research Center, Im Neuenheimer Feld 280, 69120 Heidelberg, Ge…
- Faculty of Biology, University of Freiburg, 79104 Freiburg, Germany.
Zitieren
APA
Geis, N. M., Braunwarth, Y., Meyer, P. T., Eder, M., & Eder, A. C. (2026). Optimizing PSMA-617-based inhibitors through charged linker modifications: Insights into structure-activity relationships. Theranostics. https://doi.org/10.7150/thno.118972
Vancouver
Geis NM, Braunwarth Y, Meyer PT, Eder M, Eder AC. Optimizing PSMA-617-based inhibitors through charged linker modifications: Insights into structure-activity relationships. Theranostics. 2026. doi:10.7150/thno.118972
BibTeX
@article{Geis2026,
author = {Geis, Nicolas M and Braunwarth, Yvonne and Meyer, Philipp T and Eder, Matthias and Eder, Ann-Christin},
title = {Optimizing PSMA-617-based inhibitors through charged linker modifications: Insights into structure-activity relationships},
journal = {Theranostics},
year = {2026},
doi = {10.7150/thno.118972}
}
EUVIMED